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Abstract
Cutaneous human papillomaviruses (HPVs) are considered as cofactors for non-melanoma
skin cancer (NMSC) development, especially in association with UVB. Extensively studied
transgenic mouse models failed to mimic all aspects of virus-host interactions starting from
primary infection to the appearance of a tumor. Using the natural model Mastomys coucha,
which reflects the human situation in many aspects, we provide the first evidence that only
UVB and Mastomys natalensis papillomavirus (MnPV) infection strongly promote NMSC
formation. Using UVB exposures that correspond to UV indices of different geographical
regions, irradiated animals developed either well-differentiated keratinizing squamous cell
carcinomas (SCCs), still supporting productive infections with high viral loads and transcrip-
tional activity, or poorly differentiated non-keratinizing SCCs almost lacking MnPV DNA and
in turn, early and late viral transcription. Intriguingly, animals with the latter phenotype, how-
ever, still showed strong seropositivity, clearly verifying a preceding MnPV infection. Of
note, the mere presence of MnPV could induce γH2AX foci, indicating that viral infection
without prior UVB exposure can already perturb genome stability of the host cell. Moreover,
as shown both under in vitro and in vivo conditions, MnPV E6/E7 expression also attenuates
the excision repair of cyclobutane pyrimidine dimers upon UVB irradiation, suggesting a
viral impact on the DNA damage response. While mutations of Ras family members (e.g.
Hras, Kras, and Nras) were absent, the majority of SCCs harbored—like in humans—Trp53
mutations especially at two hot-spots in the DNA-binding domain, resulting in a loss of func-
tion that favored tumor dedifferentiation, counter-selective for viral maintenance. Such a
constellation provides a reasonable explanation for making continuous viral presence dis-
pensable during skin carcinogenesis as observed in patients with NMSC.
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Author summary
Epidemiological data already strongly suggest an involvement of cutaneous papillomavi-
ruses in the development of NMSC. However, since the viral DNA is frequently lost
during progression from precursor lesions to NMSC—which is in contrast to high-risk
mucosal HPVs in the context of anogenital cancer—their etiological role is still controver-
sially discussed. Although extensively studied in experimentally infected or transgenic
models, studies in this context are still hampered by the lack of suitable preclinical models
mimicking all stages as found in humans, starting from primary infection to the appear-
ance of a tumor. Here, we provide the first evidence that only the cooperation between
UVB and cutaneous papillomavirus infection strongly favors the development of skin
tumors in the natural model Mastomys coucha. This study strongly supports the impor-
tance of cutaneous papillomaviruses in NMSC development and explains the loss of viral
DNA during malignization of UV-induced tumors, a feature commonly observed in
human SCCs.
Introduction
More than 20% of all human cancers have an infectious etiology [1]. In the case of anogenital
cancer, high-risk human papillomaviruses (HPVs) of genus alpha (α-HPVs) were identified to
be necessary and sufficient to induce cervical cancer [2]. Moreover, although still controver-
sially discussed, there is increasing evidence that infection with certain cutaneous HPVs of
genus beta (β-HPVs)—in conjunction with UV exposure—is a crucial factor in the develop-
ment of non-melanoma skin cancer (NMSC) and, particularly, squamous cell carcinoma
(SCC) [3]. NMSC is the most frequent cancer in Caucasians, especially affecting organ trans-
plant recipients (OTR) after systemic immunosuppression [4]. The risk of OTRs to get a SCC
increases up to 250-fold upon iatrogenic immunosuppression in comparison to the healthy
population [5] and the frequency of tumor formation correlates with the extent and duration
of immunosuppression [6]. Although mortality from NMSC is rare in the immunocompetent
population, it represents a considerable burden on the health-care system, particularly consid-
ering immunocompromised patients [7]. It is estimated that up to 40% of OTRs will develop
basal cell carcinomas (BCCs) and SCCs within the first 10 years after transplantation, and up
to 80% after 20 years [8]. Consequently, the proof of a causal link between cutaneous PV infec-
tion and NMSC would support the concept of a broader vaccination strategy, eliminating at
least one important cofactor of skin carcinogenesis [9].
Skepticism about an etiology of cutaneous HPVs in NMSC is mainly based on the finding
that SCCs either completely lack HPV DNA or that only a few cells are virus-positive [10],
therefore not fulfilling the first Koch postulate pointing toward an infectious causality in
tumor development [11]. However, there is current evidence suggesting that cutaneous HPVs
could act through a “hit-and-run” mechanism in which viral oncogene expression plays a role
in initiation of transformation but is ultimately no longer required for tumor maintenance
[12]. Additionally, numerous seroepidemiological reports support a role of certain β-HPVs in
NMSC development [13,14] despite their occasional absence within a malignant lesion.
The examination of the interplay between potential tumor viruses and additional risk fac-
tors requires appropriate preclinical models that mirror all stages of disease, starting from pri-
mary infection to the final manifestation of a tumor. Previously, we used the unique model
Mastomys coucha, a multimammate rodent, to investigate the role of cutaneous PVs in NMSC
formation [15]. These animals are immunocompetent and their skin becomes—similar to
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HPV in humans—infected early in their lifetime with Mastomys natalensis PV (MnPV)
[16,17], which lacks the E5 open reading frame, a typical feature of β-HPVs [18]. Lesions can
be found all over the body and are not restricted to local areas as reported for Mus musculus
PV1 (MmuPV1) in mice [19,20]. MnPV is naturally spread within our colony and follow-up
studies also allowed us to dissect the complete course of antibody responses during all stages of
infection [17,21]. In addition, a virus-free colony enables infections under defined experimen-
tal conditions [21].
In a subpopulation of our MnPV-positive colony, animals spontaneously developed benign
and, more rarely, malignant skin tumors (e.g. papillomas, keratoacanthomas, SCCs) in an age-
dependent manner that are histologically similar to lesions found in patients [15]. Based on
this property, we recently provided the proof-of-concept that a MnPV-L1 virus-like-particle
(VLP)-based vaccine could completely prevent all forms of tumor formation in these animals
even under immunosuppressive conditions as found in OTRs [21].
Since in humans more than 80% of pre-neoplastic skin lesions and NMSCs appear at sun-
exposed areas [6], particularly UVB radiation (290–320 nm) is considered as a central risk
factor for NMSC development and causes DNA photoproducts, e.g. cyclobutane pyrimidine
dimers (CPDs), that predominantly lead to C!T and rarely CC!TT transitions [22]. Physio-
logically, UVB induces activation of p53 leading to cell cycle arrest and DNA repair or—at
higher doses—to apoptosis [23]. However, if p53 function is disturbed, for example by a pre-
ceding infection with certain cutaneous HPV types, genetically damaged cells can accumulate,
thereby promoting the development of NMSC [24,25]. Although cutaneous HPVs cannot
degrade p53 as high risk α-HPV types, their E6 proteins affect many intracellular pathways
involved in cell cycle control, DNA repair and maintenance of a normal cellular phenotype
[24,26–30].
Additionally, several studies with transgenic mice indicate a mechanistic link between cuta-
neous HPV and UV exposure in the development of skin tumors [31–33]. However, these
mouse models are hampered by the fact that the constitutively expressed transgenes are recog-
nized as self-antigens and therefore only incompletely reflect a natural infection in terms of
viral expression, virus production and seroconversion.
Hence, questions still open in the context of NMSC development are the following: (i) how
do UV irradiation and viral infection favor the outcome of SCCs in immunocompetent ani-
mals; (ii) what kinds of tumors are induced and (iii) are there similarities to the situation in
humans with respect to histology, viral loads, serology and genomic signatures?
In our study we used Mastomys coucha with a low spontaneous skin tumor rate to directly
follow up the interplay of PV infection and UVB in naturally MnPV-infected animals in com-
parison to their virus-free counterparts. With this preclinical model that mimics the human
situation in many aspects, we provide the first evidence that cells naturally infected with cuta-
neous PVs are prone to NMSC development during chronic UVB exposure.
Results
UVB irradiation induces skin tumors only in MnPV-infected Mastomys
coucha
To study the effect of UV exposure, naturally MnPV-infected (MnPV+) and MnPV-free
(MnPV-) animals with an age of 14 weeks were irradiated at the shaved back three times per
week with increasing doses of UVB light (Fig 1A). The doses used in our experimental setting
were calculated based on information of the World Health Organization [34] and the German
Federal Office for Radiation Protection (BfS) [35]. For instance, 450 mJ/cm2 UVB (312 nm)
corresponds to 6h of sun exposure in Paris, France in May, where a UV index (UVI) of 6.3 is
UV and papillomavirus infection in skin cancer
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Fig 1. Study design and tumor development. A) Mastomys coucha as a model for cutaneous papillomavirus infection. In the
study, naturally MnPV-infected animals (MnPV+) as well as virus-free control animals (MnPV-) were irradiated three times per week
with UVB. The starting dose of 150 mJ/cm2 was increased weekly by 50 mJ/cm2 until the desired final dose was reached (450, 600 or
800 mJ/cm2, respectively). Black arrows indicate an increase of the dose, gray arrows the subsequent application of this dose. The
irradiation was continued until the animals were sacrificed or died. B) Kaplan-Meier curves demonstrating the percentage of irradiated
virus-infected (MnPV+, UV+), virus-free (MnPV-, UV+) and unirradiated virus-infected (MnPV+, UV-) tumor-bearing animals. C) Two
examples of spontaneous skin lesions arising in naturally infected animals. D) Examples of UV-induced keratinizing SCCs (KSCC)
UV and papillomavirus infection in skin cancer
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006723 November 30, 2017 4 / 34
reached. Accordingly, a dose of 600 mJ/cm2 is reached after the same time in New York, USA
in June (calculated UVI = 8.4) and 800 mJ/cm2 in Darwin, Australia in September (calculated
UVI = 11.1). Under these conditions, the median time for the onset of tumors was 58 weeks
for the MnPV+ colony, in which a total of 44 out of 78 animals (56%) developed single or mul-
tiple continuously growing skin tumors. Conversely, a median time for tumor development
could not be assessed for the MnPV- UV-irradiated (2 out of 37 animals, 5%) and the MnPV+
unirradiated colony (1 out of 155 animals, <1%), due to the low tumor incidence of the latter
(Table 1).
To examine the time dependency of tumor formation, we plotted these results in a Kaplan-
Meier curve (Fig 1B), showing that in the MnPV+ colony the first UV-induced skin lesions
appeared after approximately 30 weeks of irradiation. The incidence of tumor-bearing animals
among those still alive after 65 weeks reached 75% in the MnPV+ UV-irradiated colony,
whereas it did not exceed 18% in MnPV- animals. Notably, eight MnPV+ animals (all within
the 450 mJ/cm2 group) additionally developed tumors at unirradiated sites (in the ear, around
eyes or mouth), an observation that may be attributed to a systemic immunosuppressive effect
mediated by chronic UVB exposure [36].
These results show that UVB irradiation and cutaneous PV infection strongly promoted
tumor formation in MnPV+ animals that developed lesions significantly more frequently than
MnPV- animals (p = 0.0009, Mantel-Cox test) or their unirradiated counterparts (p<0.0001).
Although the cumulative UVB dose was different for the three dose groups (Fig 1A) no signifi-
cant dose-response relationship could be noted (S1 Fig).
UV-induced skin tumors comprise two distinct types of squamous cell
carcinomas
In the course of a natural infection, MnPV can induce the development of benign skin lesions
such as papillomas and keratoacanthomas (Fig 1C) [15,21]. Monitoring UV-irradiated
MnPV+ animals, however, two entities of skin tumors were observed. The first developed to
larger keratinized nodules, which often contained a central keratin plug surrounded by atro-
phic skin (Fig 1D). These keratinizing SCCs (KSCC) morphologically and histologically
resembled keratoacanthomas in humans [37,38] and were macroscopically indistinguishable
from spontaneous tumors in naturally infected animals. The presence of koilocytes in these
with similarities to human keratoacanthomas. E) Examples of UV-induced non-keratinizing SCCs (nKSCC) (C, D and E: scale bars:
10 mm). F) Number of KSCCs and nKSCCs in correlation with the final UV doses. Note that KSCCs preferentially appeared at the
lowest dose, nKSCCs preferentially at higher doses (Mean ± SEM; animal numbers: see Table 1; av: average number of tumors).
https://doi.org/10.1371/journal.ppat.1006723.g001
Table 1. Summary of the absolute numbers of tumors in the different groups, percentage of tumor-bearing animals and median time of tumor
development.
MnPV
status
Dose (mJ/
cm2)
Animals with tumors during observation time
(80 weeks)
Tumor % of
group
% total Median of tumor occurrence
(weeks)
Infected no UV 1/155 Spontaneous <1 <1 not assessable
150–450 31/56 UV-induced 55 56 56
150–600 7/12 58 58
150–800 6/10 60 61
Uninfected 150–450 1/19 UV-induced 5 5 not assessable
150–600 0/8 0 not assessable
150–800 1/10 10 not assessable
https://doi.org/10.1371/journal.ppat.1006723.t001
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lesions (S2 Fig, right panels) suggests productive PV infections [39]. Conversely, the second
tumor phenotype, referred to as non-keratinizing SCCs (nKSCC), grew faster (Fig 1E). These
relatively flat but deeply infiltrating tumors often developed ulcerations as they became larger.
Notably, in the beginning some tumors had macroscopic similarities with KSCCs and later
partially developed to an nKSCC (S3 Fig). Moreover, nKSCCs were found to be more promi-
nent in the groups with higher UV doses, suggesting that increased irradiation damage influ-
enced the tumor type (Fig 1F).
Histologically, and similarly to tumors from unirradiated sites (Fig 2A), KSCCs were char-
acterized as exoendophytic multilocular proliferations of well-differentiated neoplastic squa-
mous epithelium with different degrees of parakeratosis (Fig 2B). Hyperproliferative Ki-
67-positive cell layers were broadened and atypical keratinocytes showed expression of kera-
tins. In a transitional tumor, combining features of KSCCs and nKSCCs (Fig 2C and 2D),
areas of well-differentiated, hyperproliferative, atypical squamous cells converted into pleo-
morphic cells. These often showed a spindle cell phenotype and a diffuse Ki-67 staining. How-
ever, although still expressing cytokeratins, they changed their phenotype when migrating out
to invade deeper layers (Fig 2D, see arrows in inset), thereby forming a less differentiated
tumor. Furthermore, immunofluorescence for the basal membrane major component collagen
IV displayed a continuous staining of the dermo-epidermal junction in normal skin, which
was disrupted in an early stage carcinoma after UV-irradiation, in KSCCs as well as in nKSCCs
(Fig 3).
High MnPV DNA loads and transcription in well-differentiated KSCCs but
not in poorly differentiated nKSCCs
Human NMSCs either completely lack cutaneous HPVs or contain very low DNA loads [10],
indicating that viral oncoproteins are apparently not necessary to maintain a proliferative and
tumorigenic phenotype [40]. To determine whether the SCCs, representing distinct differenti-
ation states, contain different viral loads, we measured the amount of MnPV DNA in UV-
induced tumors by quantitative PCR. As shown in Fig 4A, no significant differences in viral
copy numbers were found in unirradiated and irradiated skins (S1 Table). Of note, however,
UV-induced SCCs significantly differed in their viral load. Well-differentiated KSCCs had a
significantly higher viral load compared to normal skin, reaching values also observed in
MnPV-induced papillomas and keratoacanthomas where virus production is taking place
[17]. Southern blot analyses of DNA obtained from different lesions and normal skin showed
episomal supercoiled and nicked circular DNA without any indication for integration (Fig
4B). In contrast, the viral load in nKSCCs was significantly lower than in KSCCs and compara-
ble to unirradiated skin (Fig 4A).
To determine whether MnPV is transcriptionally active in these tumor entities, semi-quan-
titative RT-PCRs for the spliced E1^E4 transcript were performed. Consistent with other papil-
lomaviruses [41], this was also the most abundant MnPV transcript in productive skin lesions
of Mastomys coucha [42]. The corresponding mRNAs could only be detected in tumors from
unirradiated sites and KSCCs that contained high viral loads, but not in nKSCCs with low
copy numbers or MnPV-negative lesions (Fig 4C) (see viral loads in S2 Table). However, to
examine the activity of the early and late promoter in these lesions, we further analyzed tissue
samples for E6/E7 and L1 transcription. As shown in Fig 4D, while still expressed in KSCCs,
none of these transcripts could be detected in nKSCCs. These results indicate that tumors with
an nKSCC phenotype counter-select for permissive MnPV production due to dedifferentiation
that may explain the quantitative loss of viral copies during malignant progression. To further
substantiate this assumption, we microdissected different areas from KSCCs and nKSCCs in
UV and papillomavirus infection in skin cancer
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Fig 2. Histological analyses of a non-UV tumor and UV-induced tumors. A) Tumors from unirradiated sites show
papilloma-like growth of well-differentiated neoplastic squamous cells (H&E). Especially the basal layers are
hyperproliferative as indicated by strong Ki-67 staining. Throughout all layers of the lesion, neoplastic cells strongly
express cytokeratins (pan-Cytokeratin). B) A UV-induced KSCC with well-differentiated exoendophytic proliferations of
squamous cells expressing Ki-67 throughout all neoplastic squamous layers. C and D) In some cases well-
differentiated KSCCs (C) further developed into more aggressive poorly differentiated nKSCCs (D). Proliferating altered
UV and papillomavirus infection in skin cancer
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order to match the degree of differentiation with the spatial distribution of viral loads. As
depicted in Fig 5A, KSCCs indeed showed a heterogeneous staining pattern for the viral DNA
when different areas were examined by in situ hybridization (ISH). Variations in the copy
number could also be confirmed by real-time qPCR after extracting DNA obtained from cor-
responding tumor regions. In contrast, monitoring nKSCCs, viral copy numbers decreased
from upper to lower dedifferentiated layers, being below the detection limit in the ISH
(Fig 5B). Here, based on real-time qPCR analyses, only every 10th or 100th cell retained viral
DNA. Concomitantly, IHC against Ki-67 revealed strong proliferation throughout basal and
squamous cells thereby invaded deeper layers and often changed to a spindle-like phenotype (H&E). The Ki-67
staining becomes diffuse in this process (compare insets) and cytokeratin expression is reduced. (d: dermis; e:
epidermis; f: fat; k: keratin; m: muscle; u: ulceration; t: tumor. Scale bars: macroscopic: 10 mm, overviews: 1 mm, insets
100 μm).
https://doi.org/10.1371/journal.ppat.1006723.g002
Fig 3. Collagen IV staining on tissue sections reveals invasion of keratinocytes through the basal membrane (BM). The BM was
stained against collagen IV (green). Nuclei were counterstained with DAPI (blue). Consecutive sections stained for pan-cytokeratin are shown in
comparison. A) In normal skin, the BM (white arrows) marks the barrier between epidermis and dermis. B) Early stage carcinoma formation in
UV-irradiated skin. A lack of collagen IV expression indicates the disruption of the BM (orange arrows) accompanied by downward migrating
cells (black arrow). C) In the edge region of a UV-induced KSCC, the BM is lost and invading altered keratinocytes are detectable. D) In nKSCC,
invasion of neoplastic cells is advanced as indicated by pan-cytokeratin staining. The discontinuous staining of the BM marks transition zones
where invading neoplastic squamous cells acquire a spindle cell phenotype (Scale bars: 100 μm).
https://doi.org/10.1371/journal.ppat.1006723.g003
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suprabasal layers in virus-positive KSCCs, while only a dispersed pattern could be discerned
when virus-negative nKSCCs were examined (S4 Fig, see also Fig 2).
UV-irradiated animals develop antibody responses against MnPV
capsids
While quantitative differences in the viral load only reflect the situation at a defined time
point, seroresponses against viral capsids represent a more reliable marker of preceding infec-
tions. Indeed, antibody titers against cutaneous HPV types are very stable in NMSC patients
[14,43]. To recapitulate an infectious history, we monitored final sera of all our animals for ser-
oresponses against MnPV virions in a VLP-ELISA [21]. All animals with UV-induced tumors,
except for one case with an nKSCC, showed high titers of MnPV-specific antibodies which
was not the case to such an extent for MnPV+ unirradiated animals (Fig 6A). Tumor formation
Fig 4. Molecular analyses of tumor-bearing animals. A) Viral load in tissue samples from UV-irradiated and control animals from the MnPV-
infected colony analyzed by qPCR and normalized to a plasmid standard. Samples were grouped according to their origin as indicated (ctrl skin:
skin from unirradiated animals; ui skin/UV skin: unirradiated or UV-irradiated skin from irradiated animals; KSCC/nKSCC: UV-induced SCCs;
non-UV tumor: tumors from non-UV sites of irradiated animals and spontaneous tumors from unirradiated animals). UV+/- indicates whether the
animal was UV-exposed or not (Kruskal-Wallis test, *p<0.05, ***p<0.001, nsp>0.05). B) Southern blot analysis of unirradiated and UV-
irradiated skins, a KSCC and a non-UV tumor. DNA was digested with ApaI (no cleavage site in MnPV), XbaI (one site) or XhoI (two sites) as
indicated (Form I: supercoiled; Form II: relaxed circular; Form III: linear form of MnPV). C) Semi-quantitative RT-PCR for the most abundant
MnPV E1^E4 transcript in non-UV tumors and UV-induced SCCs or the control GAPDH. D) Semi-quantitative RT-PCR for MnPV E6, E7 and L1
transcripts in non-UV tumors and UV-induced SCCs or the control GAPDH.
https://doi.org/10.1371/journal.ppat.1006723.g004
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could not be attributed to an inefficient humoral immune response, since these antibodies had
neutralizing capacity when pseudovirion-based infection assays were applied [44] (Fig 6B).
Animals in the MnPV- colony displayed no seroresponses against MnPV.
Induction of γH2AX foci and diminished CPD repair in MnPV-positive
cells and tissue sections
Beta-HPVs developed strategies to interfere with the repair machinery of their host cell which
may have deleterious effects, particularly when UV exposure is involved [45–50]. To monitor
Fig 5. Spatial analysis of viral load in UV-induced SCCs. Quantification and distribution of MnPV DNA in different microdissected
areas (specified in the HE staining) of A) a KSCC and B) a UV-induced nKSCC. Asterisks indicate the position of the respective MnPV-
specific in situ hybridization (ISH) (Scale bars: HE: 1 mm, ISH: 100 μm).
https://doi.org/10.1371/journal.ppat.1006723.g005
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these issues in our experimental system, we first analyzed the CPD repair in vitro. Here, Mast-
omys coucha keratinocytes [51] expressing retrovirally transduced MnPV E6/E7 and virus-
negative controls were irradiated with UV and incubated for different periods of time. As dem-
onstrated in Fig 7A, MnPV E6/E7 attenuates CPD repair 72h after UV exposure, indicating an
impact of MnPV on the DNA damage response. Since persisting CPDs can lead to an accumu-
lation of phosphorylated H2AX (γH2AX) [52], a surrogate marker for DNA damage and chro-
mosomal instability [53,54], we further examined the impact of MnPV E6/E7 expression and
UVB on γH2AX foci formation by immunofluorescence (Fig 7B). While there was also a weak
response in virus-negative cells as a consequence of UV exposure, in E6/E7-expressing kerati-
nocytes more foci could be quantified after 7h and 24h (Fig 7C). In control cells, these disap-
peared faster than in cells expressing E6/E7, which per se showed a higher amount of γH2AX
foci even without prior irradiation. Notably, a similar effect could also be observed in vivo by
comparing representative skin sections obtained from two MnPV- and MnPV+ animals that
were sacrificed 24h after the last irradiation. Here, epidermal keratinocytes of uninfected ani-
mals showed only a sporadic staining for CPDs and γH2AX, while skin sections of MnPV+
Mastomys exhibited a stronger positivity for both markers (Fig 7D). The skin surrounding a
KSCC shown in Fig 7E also harbored keratinocytes positive for both CPD and γH2AX, while
deeper layers of the KSCC itself were strongly positive for γH2AX but negative for CPDs (see
insets).
To determine the impact on DNA damage response in correlation with the viral load, tumor
sections were stained with an antibody directed against γH2AX. In parallel, consecutive sections
were examined by ISH for the presence of MnPV. Here, consistent with the quantification of
Fig 6. Serological analyses of the animals. A) Antibody responses of UV-irradiated and control animals against MnPV-L1-VLPs.
Final sera of 55 to 75 week old animals were measured. Animals were grouped according to their origin (MnPV+ or MnPV- colonies)
and treatment. Different groups represent distinct constellations of tumor types in the animals. Note that both MnPV- tumor-bearing
animals were included in the last group. The cut-off for the assay is indicated by the red line (titer of 300) (Mean ± SEM; Kruskal-Wallis
test, **p<0.01, ***p<0.001). B) Correlation of pseudovirion-based neutralization titers and antibody titers measured by VLP-ELISA.
The non-linear fitting indicates a correlation of 99% between both assays.
https://doi.org/10.1371/journal.ppat.1006723.g006
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Fig 7. MnPV interferes with DNA damage repair. A) Repair kinetics of CPDs in MnPV E6/E7-positive and -negative Mastomys
keratinocytes (Mean ± SD; n = 2, measurements were performed in quadruplicates). B) Immunofluorescence staining of γH2AX foci in
keratinocytes stably expressing MnPV E6/E7. Cells were irradiated with UVB and further incubated prior to detection and quantification of
γH2AX foci (Ctrl: unirradiated, UV: irradiated; Red: γH2AX, blue: nuclei; scale bars: 50 μm). C) Quantification of γH2AX foci (Mean ± SEM;
n242; 1way-ANOVA, *p<0.05, **p<0.01, ***p<0.001). D) Co-detection of CPDs and γH2AX in MnPV+/- skin harvested 24h after UV
irradiation. Arrows point towards positive cells (Viral loads: animal 3: 13.68 ± 1.66 copies/cell, animal 4: 147.42 ± 14.62 copies/cell; Scale bars:
100 μm). E) Co-detection of CPDs and γH2AX in a KSCC harvested 24h after UV irradiation (Viral load: 611.88 ± 18.75 copies/cell; scale bars:
100 μm).
https://doi.org/10.1371/journal.ppat.1006723.g007
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the viral loads (Fig 4A), a strong staining for MnPV DNA could be visualized in suprabasal lay-
ers of tumors from unirradiated sites and in UV-induced KSCCs (Fig 8). Intriguingly, there was
a clear coincidence of ISH and γH2AX signals in both lesions, indicating that apparently the
mere presence of MnPV already activates a kind of DNA damage response in terms of γH2AX
foci formation, even in a tumor never exposed to UVB. In contrast, nKSCCs with low or lacking
viral loads were negative for γH2AX. Since γH2AX foci only exist temporarily and disappear
after DNA damage repair [55], their persistence in non-UV tumors and KSCCs indicates a
Fig 8. Induction of γH2AX foci by MnPV. Co-detection of γH2AX and MnPV DNA in consecutive tissue sections. Left panel:
γH2AX staining of a non-UV tumor correlates with high viral load detected by ISH with a MnPV-specific probe (Viral load:
12065.07 ± 1119.24 copies/cell). Middle panel: the same concurrence can be detected in UV-induced KSCCs (Viral load:
26592.94 ± 1823.92 copies/cell). Right panel: UV-induced nKSCCs are negative in both stainings (Viral load: 0.98 ± 0.1 copies/
cell; scale bars: 100 μm).
https://doi.org/10.1371/journal.ppat.1006723.g008
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continuous interference with the host genome in MnPV-infected cells that may also contribute
to maintain their replication levels in a still permissive environment.
MnPV E6 does not affect p53 transactivation efficiency
Although most of the cutaneous HPV types cannot degrade p53, they can impede intracellular
signal transduction of p53, p53 family members, downstream pro-apoptotic proteins and pro-
teins involved in DNA repair [26–29,56]. To investigate the impact of MnPV E6 on p53 in the
context of tumor formation, we co-transfected cloned Mastomys coucha p53 together with
MnPV-E6 and tested its effect in p53-luciferase reporter assays (Fig 9A). Western blot analyses
were used to monitor quantitative changes of both proteins in comparison to actin (Fig 9B).
While the transactivating activity of human p53 was completely abrogated by HPV16 E6 due
to degradation (Fig 9A, right panel), there was only a marginal effect on reporter activity when
increasing amounts of MnPV E6 were transfected (Fig 9A, left panel), despite unaffected
steady-state levels of p53 (Fig 9B).
UV-induced skin tumors in Mastomys coucha acquire mutations in Trp53
similar to human SCCs
Since p53 is a major decisive factor in sensing DNA damage and due to its high mutation fre-
quency in human cancer [57,58], we sequenced Trp53 cDNA from UV-induced tumors and
analyzed its functional status. Human and Mastomys coucha p53, especially the DNA-binding
and the oligomerization domains, are extremely conserved, anticipating that mutations within
these regions may have the same functional impact as found in humans [59]. In 79% of UV-
induced SCCs (34 out of 43 samples) at least one mutation was present, which was not the case
for UV-irradiated skins (n = 7), unirradiated skins (n = 4) and lesions from unirradiated sites
Fig 9. Transactivating capacity of Mastomys p53 in the presence of MnPV E6. A) The capacity of p53 to
transactivate a p53-responsive firefly luciferase gene measured in H1299 cells transfected with reporter
plasmids and expression vectors for Mastomys p53 and MnPV E6 or human p53 and HPV16 E6 as a control.
Transactivation activity was measured by luminescence (RLU, relative light units). Cells transfected only with
p53 served as control and their RLU levels were arbitrarily set to 1 (Mean ± SEM; n = 7; 1way-ANOVA,
***p<0.0001). B) Western blots showing protein levels of p53 and E6 in the lysates of the transactivation
assay. Actin served as an internal loading control.
https://doi.org/10.1371/journal.ppat.1006723.g009
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Fig 10. Analysis of the Trp53 status in UV-induced SCCs. A) Schematic structure of Mastomys coucha p53 (based
on [113]) matched to the position and the frequency of mutated residues (n = 43). Note that residue P271 was
substituted by three different amino acids. B) Comparison of the number of Trp53 mutations in KSCCs (n = 16),
nKSCCs (n = 27) and the total number of SCCs (n = 43) (unpaired t-test, p = 0.0227). C) Frequency of mutations at
positions P145, R266 and P271 in KSCCs in comparison to nKSCCs. D) Locations of the hot-spot mutations in a 3D
model of p53. Selected residues are highlighted (source: http://p53.iarc.fr/MakeJMol.aspx). E) Hot-spot mutants were
cloned in an expression vector and tested for their capacity to transactivate a p53-responsive firefly luciferase gene.
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(n = 4), respectively. As expected, most mutations were UV-induced C!T and CC!TT tran-
sitions. Fig 10A matches frequency and localization of the mutations to the predicted domain
structure of Mastomys coucha p53. Similar to human skin cancer [57], residues R266 and P271
(R273 and P278 in human p53) in the C-terminal part of the DNA-binding domain were
found to be hot-spots for UV-induced mutagenesis. Allocating Trp53 mutations in the context
of their histopathological origin, nKSCCs harbored significantly more mutations than KSCCs
(Fig 10B). Whether these cells harbor multiple Trp53 mutations or whether this reflects tumor
heterogeneity [60] remains to be elucidated. Nonetheless, since mutations at hot-spots R266
and P271 were mostly found in nKSCCs, they apparently favored the development of a more
aggressive phenotype and seem to be inversely correlated to the viral load (Fig 10C). An in sil-
ico modelling of the binding of Trp53 to DNA (using human p53 with correlating positions)
clearly indicates the importance of R266 and P271 which are either directly involved in the
DNA binding or at least located in close proximity (Fig 10D).
To analyze the mutational impact on Mastomys coucha p53, we ectopically expressed hot-
spot mutants R266C, P271F and P271S, as well as mutant P145L in H1299 cells and tested
their ability to transactivate a p53-responsive reporter (Fig 10E). Here, the hot-spot mutants
completely lacked transactivation activity, whereas the more distal P145L mutant, which was
detected with less frequency in tumors, showed the same activity as wildtype p53. Further-
more, P145L, P271F and P271S were also less stable (Fig 10F). Conversely, although R266C
was not affected in its intracellular half-life, its ability to transactivate was lost. Even the addi-
tion of the proteasome inhibitor MG132 could not increase the transactivation efficiency of
hot-spot mutants P271F and P271S (Fig 10G), although their protein levels were stabilized (Fig
10H). In contrast to wildtype p53, the activity of P145L decreased when MG132 was applied,
probably due to cofactor squelching which counteracts its functionality [61].
IHC staining of mutant p53 in nKSCCs
Since elevated levels or stable forms of mutated p53 are frequently found in cancer cells [58],
we also stained tissue sections of UV-irradiated MnPV+ animals for p53 and cytokeratin
expression. While undetectable in unirradiated skin, p53-positive islands of squamous cells
were visible in UV-irradiated skin (S5A and S5B Fig). Furthermore, atypical squamous cells
that migrated out of the hyperproliferative epidermis of nKSCCs acquired a spindle-like mor-
phology and enhanced p53 levels (S5C and S5D Fig).
As reported elsewhere, Trp53 knockout leads to spindle cell SCCs in mice [62], suggesting
dedifferentiation after loss of functional p53 [63]. To examine this possibility for nKSCCs, we
stained consecutive tumor sections where reduced pan-cytokeratin and E-cadherin levels
matched with increased intensity of vimentin (Fig 11). Furthermore, these stainings strongly
coincided with p53-positive areas (see frames in Fig 11) in zones where transition of differenti-
ated cells into undifferentiated cells takes place. Since R266C was the only Trp53 mutation
found in this nKSCC, we argue that there is a strong relationship between loss-of-function
Trp53 mutations and dedifferentiation [64,65]. This may favor the development of tumors
independently from viral oncogene expression.
Transactivation activity was measured by luminescence (RLU, relative light units). Cells transfected with empty vector
served as control and their RLU levels were arbitrarily set to 1 (Mean ± SEM; n = 7; 1way-ANOVA, ***p<0.001). F)
Western blot showing protein levels of p53 mutants measured in the transactivation assay. EGFP was used as a
control for transfection efficiency, actin as an internal loading control. G) Same as shown in panel E. Prior to the
measurement of the transactivation, transfected cells were treated with 5 μM MG132 (Mean ± SEM; n = 4; 1way-
ANOVA, ***p<0.001). H) Western blot of transfected cells after treatment with 5 μM MG132.
https://doi.org/10.1371/journal.ppat.1006723.g010
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Discussion
Considering that more than 95% of all viral sequences found in human skin belong to β- and
γ-HPVs [66], it is essential to investigate whether a functional interaction between UV and
HPV infection exists. Indeed, both molecular and epidemiological data support a functional
contribution of some cutaneous HPVs in the time-dependent multistep process of NMSC
development [67,68]. However, there is still incongruity since viral DNA is lost during pro-
gression from actinic keratosis to cutaneous SCC [69]. This contrasts with cervical cancer
where integrated high-risk α-HPV DNA is detectable in all tumor cells [70].
Fig 11. Dedifferentiation correlates with positive p53 staining. Consecutive sections of a poorly differentiated
nKSCC were stained with antibodies against E-cadherin, vimentin, pan-Cytokeratin and p53. DAPI was used as
nuclear counter stain. Note that in this tumor, only mutation R266C could be detected (Scale bars: 100 μm).
https://doi.org/10.1371/journal.ppat.1006723.g011
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Although well studied in transgenic mice [71], research on the role of cutaneous PVs in
skin carcinogenesis is still hampered by the lack of suitable naturally infected animal models
that recapitulate a complete productive viral life cycle and subsequent immune challenge to
reflect the situation in patients. The MmuPV1 mouse model readily allows efficient formation
of cutaneous lesions. However, the amounts of viral particles needed for an experimental infec-
tion highly exceed those causing natural infections and is only successful at defined anatomical
sites and in certain mouse strains [72,73].
Here, we used the naturally MnPV-infected and immunocompetent rodent Mastomys cou-
cha to show for the first time a functional link between cutaneous PV infection, UVB irradiation
and NMSC development. Our results differ from previously published models. While in trans-
genic HPV8-E6 mice [30,33] and experimentally MmuPV1-infected mice [73], a single UVB
dose was sufficient for SCC formation, more than 30 weeks of continuous treatment were nec-
essary until the first lesions appeared at the backs of our animals (Fig 1D and 1E). Hence, these
kinetics resembles more the time course of tumor development found in HPV38-E6/E7 mice
[32] for which a similar irradiation protocol was used (Fig 1B). The time range also better
reflects the development of cutaneous SCCs in humans, which are linked to cumulative life-
long sun exposure and appear mostly in elderly patients [74,75]. Moreover, based on the contact
hypersensitivity reaction of the skin [76], a broad range of UV susceptibility in diverse rodent
strains could be noted and even hair pigmentation seems not to account for these differences
since C57 mice (highly pigmented) are much more susceptible to UV than BALB/c albino mice
([77] and references herein). We therefore applied three different final doses of UVB to monitor
the onset of tumor development, but the kinetics of NMSC development was independent of
the intensities used here (S1 Fig). It became evident, however, that MnPV+ Mastomys coucha
developed skin tumors at the UVB-irradiated back significantly more frequently than MnPV-
irradiated or MnPV+ unirradiated controls, clearly demonstrating a cooperative effect between
MnPV infection and UV on SCC formation (Fig 1B).
UVB intensity, however, influenced the appearing tumor type. The cohort irradiated with a
final dose of 450 mJ/cm2 UVB more often developed KSCCs (Fig 1D and 1F) compared to ani-
mals that received higher doses, in which especially nKSCCs were obtained (Fig 1E and 1F).
The location of SCCs in Mastomys coucha also contrasts with the MmuPV1 mouse system
where lesions preferentially develop at the tail, muzzle or ear, while the back skin was less pre-
disposed or even resistant [19,72]. The putative underlying reason was recently addressed in
an elegant study using quantitative trait loci network analysis in mice [78]. According to this
report, dorsal and tail skin is not only dissimilar by different keratin networks and transcrip-
tion factors, but also due to their lower expression of markers for tissue-resident Langerhans
cells and MHC expression. Since both are involved in the immune response against PVs [79],
their depletion may account for the local susceptibility to MmuPV1 infection and papilloma
formation in the murine system.
The tumor entities found in our study could be histopathologically identified either as a
well-differentiated type (KSCC, Fig 2B) or as a more aggressively growing poorly differentiated
type (nKSCC; Fig 2D) [38], mainly composed of deeply invading pleomorphic spindle cells
infiltrating the underlying dermis (Fig 3). Human cutaneous SCCs with a spindle cell compo-
nent could be found in almost 20% of immunosuppressed patients, showed aggressive growth
[80] and usually appear in heavily sun-damaged skin areas [81]. It is therefore tempting to
speculate that nKSCCs preferentially obtained at higher UVB doses represent a more pro-
gressed phenotype as a result of the acquisition of additional driver mutations during carcino-
genesis. This is in line with the observation of some intermediate tumors evolving from
KSCCs (S3 Fig). While previous studies have not yet shown a correlation between viral load
and the differentiation status of SCCs, we addressed this question in our preclinical model.
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Regarding MnPV DNA, KSCCs harbored viral loads comparable to tumors appearing at
sites unexposed to UVB, although a trend towards lower amounts could be noted (Fig 4A). In
both entities, MnPV was episomal (Fig 4B) and transcriptionally active as demonstrated by
detection of the spliced E1^E4 transcript, previously found to be the most abundant in produc-
tive infections [42]. These lesions still showed early and late transcription, since E6/E7 and L1
specific transcripts could be detected (Fig 4C and 4D). Conversely, the viral load was signifi-
cantly lower or even absent in nKSCCs (Fig 4A, see also S1 Table) that in turn of course also
explains the lack of viral mRNA in these tumors (Fig 4C and 4D). This is consistent with epide-
miological studies reporting still high levels of transcriptionally active HPV in actinic kerato-
ses, but not in SCCs [69]. The significant loss of viral DNA in nKSCCs also diverges from
another model hitherto used for skin carcinogenesis, namely the infection of domestic rabbits
with cottontail rabbit PV (CRPV) [82]. Here, malignant skin tumors still contain high copy
numbers of transcriptionally active CRPV DNA [83], thereby only limitedly reflecting the situ-
ation in humans.
The viral load only represents a current status that may change during the multi-step pro-
cess of skin carcinogenesis [5]. Therefore, a more reliable parameter for detecting a preceding
infection—especially in animals that developed nKSCCs with negligible residual amounts of
viral DNA in these tumors—was the determination of antibody responses against MnPV cap-
sids using a VLP-ELISA (Fig 6A) [21]. Seroconversion is very stable, especially for cutaneous
HPVs [84], and therefore represents the only proof of an infectious history in SCCs when viral
DNA is barely discernible or absent [43]. Newborn and still uninfected Mastomys coucha are
completely seronegative for MnPV early and late proteins, but develop strong responses sev-
eral weeks after viral infection [21]. Although serum responses showed considerable individual
variability, animals with well-differentiated KSCCs had the highest titers which probably can
be attributed to a stronger immune exposure due to a productive viral infection. The titers
were more dispersed in the group of animals with poorly differentiated nKSCCs than in
those with KSCCs (variation coefficient 94% vs. 59%, p<0.001), which may reflect the quanti-
tative loss of MnPV in these lesions (Figs 4A and 5) and the absence of a continuous immune
challenge. Thus, dedifferentiation of squamous cells interferes with viral replication and matu-
ration [85], resulting in a reduced amount of viral particles and in turn an insufficient presen-
tation of new virus progenies to the immune system. One animal of the nKSCC group was
even seronegative, indicating that here tumor formation was probably only caused by UVB
exposure alone as found in the two MnPV- controls which also developed tumors. Of note,
throughout all groups, VLP-specific antibody responses in final sera correlated well with
their neutralizing capacity in pseudovirion-based neutralization assays (Fig 6B). These results
support the notion of a still functioning humoral immune surveillance during chronic UV
exposure.
Host cell dedifferentiation can interfere with replicating episomal DNA and favor its inte-
gration, as known for high-risk α-HPVs [86,87]. However, integrated cutaneous HPVs were
never reported [68], implying other selection mechanisms that allow growth advantage
through genomic driver mutations, making PVs finally dispensable for the maintenance of a
malignant phenotype. This was demonstrated by spatial microdissection of a nKSCC (Fig 5B),
harboring mutated p53 (R266C) that was completely inactive in the transactivation assay (Fig
10B and 10C).
In any case, cancer has to be considered an evolutionary process [88] in which MnPV is
apparently contributing to the first steps of tumor initiation by enhancing the probability for
tumor formation, as can be concluded when the outcome of UVB irradiation on infected and
uninfected animals is compared (Fig 1A).
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Considering the mechanism of DNA damage in general, however, normal cells either
undergo a p53-dependent cell cycle arrest that allows DNA repair or they are eliminated by
apoptosis [89]. However, certain cutaneous HPVs developed ways to circumvent physiological
DNA-damage responses, either by inactivating HIPK2-mediated phosphorylation of p53 and
subsequent apoptosis [25] or by targeting the pro-apoptotic protein Bak for degradation
[48,90]. In combination with a delay of DNA repair mechanisms such as excision of UV-
induced CPDs (Fig 7A) [26] or homology dependent repair [29], the accumulation and prolif-
eration of UV-damaged stem-like cancer cells can be favored [91].
As already reported more than a decade ago, HPV5 and HPV8 can diminish the excision
repair of UV-induced cyclobutane pyrimidine dimers (CPDs) [26], which can lead to the gen-
eration of DNA double-strand breaks (DSBs) by DNA replication fork collapse during S-phase
[52]. In fact, this previously described mechanism leads to an attenuated CPD repair and per-
sisting γH2AX foci in HPV5 and HPV8 E6 positive human keratinocytes in vitro and in epi-
thelial cells after UV irradiation of HPV8 E6 transgenic mice [33]. Although UV irradiation
itself also induces γH2AX foci [92], they disappear after repair, allowing the cells to proliferate
again [55]. In wounded skin of HPV8-E6 transgenic mice, γH2AX foci could also be observed,
probably as a result of reactive oxygen species that appear during healing and interfere with
transcription or activity of DNA repair enzymes [50].
In line with this assumption is the finding that in vitro MnPV E6/E7 expression attenuated
CPD repair in Mastomys coucha keratinocytes (Fig 7A). This may have led to an enhanced
number of DSBs and in turn γH2AX foci in E6/E7-expressing keratinocytes when compared
to E6/E7-negative cells (Fig 7B) which disappear more slowly. Repair kinetics apparently dif-
fers with respect to previous studies [26,93–95] which can, however, be attributed to different
experimental settings, cell types and UV sources and doses. Nevertheless, comparing irradiated
skin of MnPV- and MnPV+ animals (Fig 7D), the same scenario as described above could be
discerned, suggesting that—similar to human cutaneous HPV types—MnPV can interfere
with DNA damage responses both under in vitro and in vivo conditions.
Notably, MnPV apparently can induce γH2AX foci even without additional UVB exposure
(Figs 7E and 8). Histone H2AX can be phosphorylated upon genotoxic stress by upstream
kinases such as ATM/ATR along with the DNA-dependent protein kinase (DNA-PK) [53].
In UV-induced KSCCs with high viral loads, ISH signals and γH2AX staining coincided,
mostly in suprabasal layers where substantial viral replication is taking place [70]. In contrast,
nKSCCs with low amounts of viral DNA were negative for both signals because these tumors
lack the capacity to differentiate (Fig 11). This may reflect an ATM-dependent DNA damage
response in such lesions, known to be essential for viral DNA amplification in differentiated
cells [96,97]. How a permissive environment for MnPV with early and late transcription is
altered during dedifferentiation where the viral DNA is lost, is currently unknown and awaits
further elucidation.
Consistent with many human cutaneous HPVs [24], but in contrast to HPV16 E6, MnPV
E6 is not degrading p53 and can only marginally affect its transactivating function (Fig 9A and
9B). Based at least on this experimental read-out, MnPV may affect other pathways that
account for enhanced tumor incidence when compared to virus-free animals (Fig 1B). Nota-
bly, a complete novel view about the oncogenic potential of “high-risk” cutaneous HPVs has
recently been reported for HPV8, a skin type involved in the development of the rare heredi-
tary disease Epidermodysplasia verruciformis (EV) [98]. Here, the E6 protein has been shown
to down-regulate the microRNA-203 that both interferes with cell differentiation and up-regu-
lates ΔNp63, another member of the p53 family. This finding reasonably explains the potential
of HPV8 to hinder differentiation and in turn its capacity to stimulate proliferation of undif-
ferentiated cells [99].
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UV as an environmental carcinogen damages the DNA by forming photoproducts that
mainly lead to C!T and CC!TT transitions at sites of neighboring pyrimidines, therefore
known as UV signatures [22]. Considering the mutational landscape, TP53 is the most fre-
quently mutated gene in human SCCs [100]. Likewise, sequence analysis of Mastomys coucha
Trp53 also showed mutations in 79% of all UV-induced SCCs. Setting the frequency of Trp53
mutations into a histopathological context, more mutations were found in nKSCCs than in
KSCCs (Fig 10B and 10C). Analyzed mutations resulted either in a loss of transactivation activ-
ity (Fig 10E), a reduced intracellular half-life (Fig 10F) or both. The two hot-spots R266 and
P271 within the DNA-binding domain (Fig 10A) correspond to positions R273 and P278 in
human cancer in general (R273) and cutaneous SCCs in particular (P278) [101]. Reconstitu-
tion of the intracellular half-life by proteasome inhibition did not restore the transactivation
capability of mutants P271F and P271S, arguing against an inverse correlation between the
amount of p53 and its ability to transactivate p53-responsive reporter genes (Fig 10G and
10H). Although still active in the reporter assay and therefore probably not contributing to car-
cinogenesis by a loss of transactivation activity, P145L also displayed a reduced half-life, proba-
bly due to the substitution of proline and subsequent enhanced degradation of the misfolded
protein [102]. Indeed, similar to human SCCs [100], Mastomys also developed SCCs that still
carried wildtype Trp53 (Fig 5, left and middle panel), but additional potential driver mutations
may have substituted this function.
Although TP53 is the most frequently mutated gene in human SCCs, also other potential
driver mutations have been identified [100,103]. In the context of the tumors developed in
Mastomys coucha, we focused our attention on RAS-family members, since UV predominantly
induces C!T and CC!TT transitions [22] that are frequently found at hot spot positions in
codon 12 of the HRAS and KRAS genes [104]. However, as far as KSCCs and nKSCCs were
tested, irrespective of the Trp53 status, no activating mutations in H, K or Nras (codons 12,
13 and 61) could be detected (S3 Table). Nonetheless, taking Trp53 as a surrogate genome
sequence, it is obvious that cells in nKSCCs generally acquired more genomic mutations than
cells in KSCCs. Nonetheless, it is reasonable to assume that loss of p53 function is predisposing
cells to skin carcinogenesis, since a high mutation frequency could already be detected in pre-
malignant actinic keratoses [105]. Islands of hyperproliferative squamous cells with elevated
p53 could already be found in UV-irradiated skin (S5B Fig), indicating that those patches may
represent an early event in skin carcinogenesis. However, the time frame and temporal order
of events favoring KSCC and nKSCC development in our model are unknown and currently
under investigation.
Loss of functional epidermal Trp53 in mice leads to the development of poorly differenti-
ated SCCs, supporting a decisive role of mutated p53 on the phenotype of squamous cells and
invasion [62]. Recently, Tovy et al. showed that p53 deficiency in mouse embryonic stem cells
leads to deregulated DNA methylation patterns, increases phenotypical heterogeneity of these
cells and interferes with their differentiation [106]. Early functional loss of epidermal p53 may
also account for the histological diversity of the tumor types in our system, as recently shown
in a knock-out mouse model [107]. Therefore, loss of functional p53 in a nKSCC harboring
p53 mutant R266C (Fig 11) may favor dedifferentiation [64] which could explain the differ-
ences in viral load between KSCCs and nKSCCs.
In conclusion, this is the first study showing cooperation between cutaneous PV infection
and UVB radiation in SCC formation in naturally infected animals. It can be considered as a
paradigm for a frequent cancer initiated by a cutaneous papillomavirus which is finally no lon-
ger required to maintain the malignant state (Fig 12), a situation commonly found in SCCs
from patients. With this preclinical model, we are currently investigating the role of skin papil-
lomaviruses at different stages during NMSC development.
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Fig 12. Schematic overview of the mechanism suggested for UV-induced NMSC development in Mastomys coucha. A) MnPV
infects basal epithelial cells of the skin of young animals via small injuries. B) MnPV genome is amplified in stratified skin layers (pink and
red nuclei) and new virions are released. C) UVB irradiation of the skin. D) UVB-irradiated skin is hyperproliferative, favoring viral
replication and virion formation. UVB-induced photoproducts, e.g. in Trp53, occur in keratinocytes (altered nuclei). In uninfected cells,
damages are repaired. In infected cells, MnPV-E6/E7 reduce chromosomal stability and inhibit DNA repair. Mutations can accumulate
and altered cells become neoplastic. E) Neoplastic squamous cells (light blue) start forming a well-differentiated keratinizing SCC, still
representing a permissive system that allows viral replication and formation of virions. F) When neoplastic squamous cells accumulate
further mutations (dark blue), a spindle cell phenotype is acquired, forming a poorly differentiated SCC that may become ulcerated. MnPV
cannot replicate in dedifferentiated cells and the viral DNA is subsequently lost.
https://doi.org/10.1371/journal.ppat.1006723.g012
UV and papillomavirus infection in skin cancer
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006723 November 30, 2017 22 / 34
Materials and methods
Ethics statement
The animal facility of the German Cancer Research Center has been officially approved by
responsible authority (Regional Council of Karlsruhe, Schlossplatz 4–6, 76131 Karlsruhe, Ger-
many). The official approval file number is Az 35–9185.64BH DKFZ. Housing conditions are
thus in accordance with the German Animal Welfare Act (TierSchG) and EU Directive 2010/
63/EU. Regular inspections of the facility are conducted by the Veterinary Authority of Heidel-
berg (Bergheimer Str. 69, 69115 Heidelberg, Germany). All experiments were in accordance
with the institutional guidelines (designated veterinarian according to article 25 of Directive
2010/63/EU and Animal-Welfare Body according to article 27 of Directive 2010/63/EU) and
were officially approved by Regional Council of Karlsruhe (File No G26/12).
Animals
Mastomys coucha from the DKFZ colonies were maintained under SFP conditions in individu-
ally ventilated cages (Tecniplast GR900) or in type 3 cages in positive pressure isolators on
aspen bedding with curled wood wool as environmental enrichment. Mastomys were con-
stantly kept in a light/dark cycle of 14/10h, an average temperature of 22+/-2˚C and a humidity
of 55+/-10% according to Directive 2010/63/EU, appendix III and the German legislation.
Mastomys were fed ad libitum (Mouse and Rat Maintenance No. 3437, KLIBA NAFAG, Kai-
seraugst, Switzerland) and had unlimited access to autoclaved water.
Virus-free animals were obtained by hysterectomies of pregnant Mastomys coucha under
sterile conditions and kept in a specific pathogen free isolator unit with positive air pressure at
the DKFZ [21]. To confirm the virus-free status of the animals, sera and skin samples are regu-
larly tested by ELISA (E2 and L1) and PCR, respectively.
UV irradiation of animals
Anesthetized animals (3% isoflurane) were irradiated three times per week with UVB at the
shaved back in Bio-Spectra cabinets (Vilber Lourmat, Eberhardzell, Germany) with an energy
output of 312 nm (UVB) until desired doses were reached. As an example, for achieving a dose
of 450 mJ/cm2, the irradiation time was about 2 min. During irradiation, the animals were cov-
ered with a lid with windows of 2x3 cm to only expose the shaved area of the back. Fourteen
weeks-old animals were irradiated with a starting dose of 150 mJ/cm2 which was increased
weekly by 50 mJ/cm2 [32]. To investigate the effect of UVB on tumor development, three
groups were established (with final doses of 450, 600 and 800 mJ/cm2, respectively). The irradi-
ation was then pursued with the final doses until the animals had to be sacrificed. Animals
were checked weekly for the appearance of tumors.
Immunohistochemistry (IHC)
Skin biopsies and tumors were cut longitudinally with scalpels and fixed in 4% buffered para-
formaldehyde, embedded in paraffin, sliced in one to four μm thick sections and either stained
by H&E or used for IHC with the following primary antibodies: anti-Cytokeratin, pan-specific
(C-11) (1:100; F3418; Sigma-Aldrich, St. Louis, Missouri, USA), anti-p53 Pab240 (1:30; sc-99;
Santa Cruz Biotechnology, Dallas, Texas, USA), anti-Ki-67 (1:200; IHC-00375; Bethyl Laborato-
ries, Montgomery, Texas, USA), anti-CPD TDM-2 (1:600; NMDND001; Cosmo Bio, Carlsbad,
California, USA), anti-γH2AX (1:550; MABE205; EMD Millipore, Billerica, Massachusetts,
USA) and anti-Collagen IV (1:50; CL50451AP; Cedarlane, Burlington, Canada). Antigen
retrieval was achieved after deparaffinization by heating of the sections for 15–30 min in citrate
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buffer (pH 6.0) for pan-Cytokeratin, Ki-67, CPDs and p53 or in EDTA (pH 9.0) for γH2AX.
For collagen IV staining, the sections were treated for 5 min with 0.05% trypsin. Endogenous
peroxidases were blocked with Dako REAL peroxidase blocking solution (Agilent Technologies,
Hamburg, Germany) followed by blocking with the Avidin/Biotin Blocking Kit (Linaris Biolo-
gische Produkte, Dossenheim, Germany) for 10 min per solution and with 1% BSA/10% goat
serum/PBS for 1 h. Between each step, sections were washed for 1 min in PBST (0.5% Tween-
20 in PBS). Primary antibodies were diluted in 1% BSA/5% goat serum/PBS and applied over-
night at 4˚C in a wet chamber. Ki-67 was further detected with the Alkaline Phosphatase/Anti-
Alkaline Phosphatase Method as described before [108]. For detection of E-Cadherin and
vimentin, the sections were subsequently washed three times for 5 min with PBST, incubated
for 45 min with AlexaFluor-594 goat anti-rabbit IgG or AlexaFluor-488 goat anti-mouse IgG in
1% BSA/5% goat serum/PBS (1:1,000; Invitrogen, Carlsbad, California, USA) and washed again
three times with PBST. Nuclei were stained for 10 min with DAPI (0.3 μg/ml in PBS) prior to
four washes for 5 min in PBS. The other antigens were detected with the Dako REAL Detection
System, Peroxidase/AEC, Rabbit/Mouse: Biotinylated secondary antibodies were applied for 20
min followed by washing and incubation with streptavidin-peroxidase for 20 min. After wash-
ing AEC/H2O2 substrate solution (Sigma) or SignalStain DAB Substrate (Cell Signalling Tech-
nology, Danvers, Massachusetts, USA) was added. The color reaction was stopped with distilled
water followed by counterstaining with hemalum solution (Carl Roth, Karlsruhe, Germany).
Sections were mounted with Dako Faramount Aqueous Mounting Medium, covered and
imaged with a Keyence BZ-9000 Microscope.
In situ hybridization (ISH)
Tissue sections were hybridized with a biotinylated full-length MnPV-probe using the Biotin-
Nick-Translation-Mix (Roche, Mannheim, Germany). A biotinylated pBR322 probe served as
negative control. Probes were detected with streptavidin-conjugated HRP (HRP-SA) included
in the Tyramide Signal Amplification Kit (PerkinElmer, Waltham, Massachusetts, USA) as
described elsewhere [15] with the following changes: sections were cooked for 10 min in citrate
buffer (pH 6.0) in a steam pot and digested with proteinase K (2 μg/ml in 0.05 Tris/HCl pH 7.5
at 37˚C for 12 min). Endogenous peroxidases were blocked for 10 min with 3% H2O2 in Tris-
buffered saline (TBS). The pre-hybridization mix was applied for 3 h at room temperature.
Sections were incubated with the hybridization mix (includes 300 ng/ml probe) at 42˚C for 16
h and then washed on a magnetic stirrer for 10 min in 2x SSC (42˚C), 1x SSC (room tempera-
ture) and 0.5x SSC (room temperature) before blocking with 20% goat serum/25% TNB buffer
in TBS for 45 min. The sections were incubated for 30 min with HRP-SA (1:250 in 10% goat
serum/25% TNB buffer in TBS) and washed three times for 3 min in TBS. The signal was
amplified by an incubation with biotinyl tyramide (1:50 in Amplification Diluent) for 20 min
followed by a second incubation with HRP-SA and three washes. Staining with the AEC stain-
ing kit (Sigma-Aldrich) and following steps were performed as described for IHC.
Preparation of nucleic acids from tissue
Sacrificed shaved animals were shock-frozen in liquid nitrogen and the epidermal layer was
scratched to a powder with a scalpel and collected onto aluminum foils placed on dry ice to
keep the cold chain. The obtained skin powder was transferred to pre-cooled reaction tubes
and stored at -80˚C. From tumors, thin slices were cut with a scalpel and also deep frozen. To
avoid cross contamination, surgical instruments and aluminum foils were changed after every
single sample. The DNA was extracted as described elsewhere [17]. RNA was isolated and
reverse transcribed as previously described [51]. To extract genomic DNA from specified areas
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of SCCs, one to two 3 μm-thick sections were deparaffinized. Microdissection was performed
using an EVOS Core Cell Imaging System and a cannula. Dissected groups of cells were trans-
ferred into a reaction tube and lysed overnight in a ThermoMixer (Eppendorf, Hamburg, Ger-
many) at 56˚C and 600 rpm in 25 μl Chelex 100 Resin (5% w/v suspended in water) (Bio-Rad,
Hercules, California, USA) and 5 μg Proteinase K (Gerbu, Heidelberg, Germany). The suspen-
sion was vortexed for 10 sec, boiled for 8 min and centrifuged for 3 min at 12,000 g to pellet
the Chelex resin. Two to five μl of the supernatant were used as a template for the qPCR.
RT-PCR
GAPDH, Trp53, H/K/Nras and the viral E1^E4, E6, E7 and L1 cDNAs were amplified by PCR
using PRECISOR High-Fidelity DNA Polymerase (BioCat, Heidelberg, Germany) and appro-
priate forward and reverse primers (see S4 Table for primer summary) from 20–50 ng of
reverse transcribed RNA according to the manufacturer’s protocol. Thermal cycling condi-
tions for PCRs were based on a primary denaturation step at 98˚C for 2 min, followed by 26–
37 cycles of 30 sec at 98˚C, 20 sec at 57–60˚C, 30 sec at 72˚C and a final extension step of 5
min at 72˚C. DNA fragments were separated by agarose gel electrophoresis, stained and visual-
ized by UV light. For sequencing of Trp53 and H/K/Nras cDNAs, PCR products were extracted
from agarose gels with the QIAquick Gel Extraction Kit (Qiagen, Hilden, Germany) and
sequenced with appropriate primers (see S4 Table) by the GATC Biotech Sanger Service
(GATC Biotech, Konstanz, Germany). Chromatograms were analyzed with Chromas 2.5.3
(Technelysium, South Brisbane, Australia). Trp53 mutations were detected by alignment of
wildtype Mastomys Trp53 cDNA with cDNA obtained from tumors.
Detection of MnPV status in animal samples by Southern blot
hybridization
Extracted DNA was digested with ApaI, XbaI or XhoI as indicated in the figure legend.
Four μg DNA were digested for 8 h at 37˚C prior to electrophoretic size separation of frag-
ments in a 0.8% agarose gel. The DNA was blotted overnight onto a GeneScreen Plus Hybrid-
ization Transfer Membrane (PerkinElmer). The filters were hybridized with a 32P-dCTP
labeled unit-length MnPV DNA as previously described [16].
Quantitative PCR
Quantification of MnPV DNA was performed as previously described with 50 ng of total
DNA, the iTaq Universal SYBR Green Supermix (Bio-Rad, Hercules, California, USA) and
forward/reverse primers for the MnPV-L1 gene and the single-copy-number gene β-Globin to
determine the number of input cell equivalents (see S4 Table) [21]. MnPV DNA copy numbers
were determined in duplicate by using standard curves generated in the same PCR run with a
standard containing MnPV and β-globin plasmids. MnPV DNA load was defined as the num-
ber of MnPV genomes per two β-globin copies [109]. Sensitivity of the method was 5 MnPV
genomes per sample and quantification was linear from 5 to 5 × 108 MnPV copies. For popula-
tion comparisons, all samples from animals of the MnPV+ colony were grouped according to
their tissue type.
Serological analyses
Blood was collected in a 1.5 ml reaction tube after puncture of the submandibular vein and
incubated until it was clotted. After centrifugation at 6200 g the serum was transferred into a
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fresh reaction tube and stored at -20˚C. Seroresponses against MnPV capsids were measured
with a VLP-ELISA as described elsewhere [21].
Cloning of p53 expression vectors
The Mastomys coucha wildtype p53 (p53wt) coding sequence was amplified from cDNA
obtained from freshly isolated keratinocytes and cloned into the pPK-CMV-E3 expression vec-
tor (PromoKine, Heidelberg, Germany) enabling expression of proteins tagged to HA [51].
Mutants of p53 (P145L, R266C, P271F and P271S) were produced by site-directed mutagenesis
of the pPK-p53wt vector using appropriate forward and reverse primers (see S4 Table). In
25 μl reactions 200 ng of template plasmid were amplified with 1.25 U Pfu DNA polymerase
(Thermo Fisher Scientific, Waltham, Massachusetts, USA), 2 μM mutagenesis primer pair and
400 μM dNTPs. The reaction mixture was heated to 95˚C for 2 min followed by 18 cycles of
95˚C for 30 s, 60˚C for 50 s and 68˚C for 10 min and one step at 68˚C for 7 min. The template
vector was digested with 10 U DpnI (New England Biolabs, Frankfurt am Main, Germany) for
1.5 h at 37˚C. Chemically competent E. coli were transformed with 5 μl of the reaction mix.
The desired mutation was verified by sequencing of plasmids obtained from single bacterial
clones.
Cell culture and transactivation reporter assay
The functionality of Mastomys coucha wildtype and mutant p53 was tested in a transactivation
assay as described before [51]. Briefly, H1299 cells (a kind gift from T. Hofmann, DKFZ) lack-
ing endogenous p53 were co-transfected with pPK-p53 expression plasmid, pG13-luc reporter
plasmid encoding firefly luciferase under the control of the p53 consensus binding site of the
p21 promoter and pRL-TATA encoding a TATA box-driven Renilla luciferase for normaliza-
tion of the signals. To investigate the effect of E6 on p53, cells were additionally transfected
with increasing amounts (0, 250, 500 or 750 ng) of MnPV-E6 expression plasmid (pCMV-
3tag_MnPV-E6). As a positive control for this setup, cells were transfected with human p53
(in pPK) and increasing amounts (0, 250, 500 or 750 ng) of HPV16-E6 (pCMV-3tag HPV16-
E6). Transfections were performed in duplicates either in the absence or presence of 5 μM
MG132 (LifeSensors, Malvern, Pennsylvania, USA). Twenty-four hours after transfection,
samples were harvested and reporter activity was measured with the Dual-Luciferase Reporter
Assay System (Promega, Fitchburg, Wisconsin, USA) according to the manufacturer’s proto-
col in a Synergy2 reader (BioTek, Bad Friedrichshall, Germany).
CPD ELISA
Kera5 cells were cultured for various periods after irradiation with 25 mJ/cm2 UVB and geno-
mic DNA was isolated using the DNeasy kit (Qiagen). The amounts of CPDs were determined
by an ELISA using anti-CDP antibody TDM-2 as previously described [110]. Briefly, harvested
DNA was denatured for 10 min at 99˚C and chilled on ice for 15 min. Fifty ng/well DNA in
50 μl were loaded to protamine sulfate pre-coated polyvinylchloride microtiter plates and incu-
bated at 37˚C to evaporate the liquid. The wells were washed five times with PBS-T (0.05%
Tween-20) prior to 30 min incubation with 150 μl/well 2% FCS in PBS at 37˚C. The wells were
washed again and 70 μl of TDM-2 (1:1,000) were added. After 30 min at 37˚C and five washes,
100 μl/well of anti-mouse IgG (1:10,000; W402B, Promega) were added and incubated again
for 30 min. After five washings, 100 μl/well substrate solution (10 mg ABTS, 4 μl H2O2 (35%),
10 ml Citrate-phosphate buffer (pH4.2) were added. The color reaction was measured at 405
nm with a SPECTROstar Nano (BMG LABTECH, Ortenberg, Germany).
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Quantification γH2AX of foci after UV irradiation
Kera5 cells obtained from Mastomys coucha skin were obtained and cultured as previously
described [51], retrovirally transduced with pLXSN (empty vector or coding for MnPV-
E6/E7) [111], selected and checked via RT-PCR for expression as described elsewhere [90].
For UV irradiation, cells grown on glass cover slides were washed once with PBS and irradi-
ated with 50 mJ/cm2 of UVB (Waldmann UV181BL (Waldmann, Villingen-Schwenningen,
Germany) with an output range of 280–320 nm as measured with a detector (Waldmann
Variocontrol). After 7, 24, 48 and 72 h of further incubation, the cells were subsequently
washed for 5 min with PBS, fixed for 10 min with 4% PFA, blocked for 1 h with 1% BSA/
0.5% Triton X-100 in PBS and incubated with anti-γH2AX antibody (1:650; MABE205;
EMD Millipore) for 1 h at room temperature. The cells were washed three times for 5 min
in PBS prior to incubation with AlexaFluor-594 goat anti-rabbit IgG (1:1,000; Invitrogen)
for 45 min at room temperature. The cells were subsequently washed in PBS, nuclei were
stained for 10 min with DAPI (0.3 μg/ml in PBS), washed again four times for 5 min in PBS
and mounted with Aqua-Poly/Mount (Polysciences, Hirschberg an der Bergstraße, Ger-
many). Cells were imaged with a Keyence BZ-9000 Fluorescence Microscope and γH2AX
foci analysis was performed using a FIJI (ImageJ) [112] macro developed at DKFZ Light
Microscopy Core Facility. Shortly, the Find Maxima tool with Segmented Particles above
lower threshold option was used for segmentation, and Analyze Particles tool was used for
foci scoring.
Western blotting
H1299 cells were transfected with 1.5 μg of p53 expression plasmids and 250 ng pEGFP-N1
(transfection control) using Lipofectamine3000 according to the manufacturer’s protocol and
harvested 18 hours after transfection. To monitor potential differences of p53 stability, trans-
fected cells were treated with 5 μM MG132 8–12 hours prior to harvesting. After treatment or
transfection cells were collected, washed in PBS and lysed for 30 min on ice in RIPA buffer (20
mM Tris pH 7.5, 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% NP-40, 1% sodium deoxy-
cholate) including 1x cOmplete Protease Inhibitor Cocktail (Roche). Extracts obtained from
the transactivation assay were used without adding additional inhibitors. Lysates were centri-
fuged for 30 min at 4˚C and 17,000 g and supernatants were quantified using Bio-Rad Protein
Assay Dye Reagent Concentrate (Bio-Rad). Thirty μg of denatured cell lysate/lane were loaded
to 12% SDS-PAGE. After blotting, proteins were detected with anti-HA (3F10, Roche), anti-
GFP (sc-8334, Santa Cruz), anti-FLAG M2 (F3165, Sigma-Aldrich) or anti-mouse-actin anti-
bodies prior to detection with goat anti-mouse-HRP (W402B, Promega) or goat anti-rat-HRP
(Jackson ImmunoResearch, Newmarket, UK).
Alignments
Murine Trp53 (Gene ID 22059) and human TP53 (Gene ID 7157) served as reference
sequences for alignments with Mastomys coucha Trp53 (GenBank Accession: KY626317)
using Clustal 2.0.12.
Statistical analysis
Data analyses and graphic representations were performed with GraphPad Prism 5.0 Software
and the respective statistical test indicated in the figure legends at 95% confidence interval and
a p-value of 0.05 to assess significance.
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Supporting information
S1 Fig. Kaplan-Meier curves for the tumor incidence in the different dose groups. Kaplan-
Meier curves depicting the percentage of irradiated virus-infected (MnPV+, UV+) and virus-
free (MnPV-, UV+) tumor-bearing animals divided by dose groups. The legend indicates the
final UVB doses respectively (Mantel-Cox test; MnPV+: all differences nsp>0.05; MnPV-: not
assessable).
(TIF)
S2 Fig. H&E stainings of a non-UV tumor (A) and a UV-induced KSCC in MnPV+ animals
(B). Both entities are composed of well-differentiated hyperproliferative atypical squamous
cells. Higher magnifications reveal koilocytes [enlarged, crenated nuclei with perinuclear
halos] (insets, arrows) indicative for papillomavirus infection (d: dermis; e: epidermis; f: fat; k:
keratin; scale bars: overviews: 1 mm, insets: 100 μm).
(TIF)
S3 Fig. Progression of a keratinized lesion towards a partially non-keratinized lesion. Over
time, a lesion which first was keratinizing (white arrows) progressed to a tumor that partly
looked like an nKSCC (blue arrow) and partly like a KSCC.
(TIF)
S4 Fig. IHC stainings for Ki-67 in KSCC and nKSCC. Areas shown correspond to the insets
in Fig 5. (A) KSCC. (B) nKSCC. (Scale bars: 100 μm).
(TIF)
S5 Fig. IHC stainings for p53 and pan-cytokeratin reveal elevated p53 levels in invading
squamous cells. A) Unirradiated skin without detectable p53 signals. B) Islands of basal kera-
tinocytes show strong nuclear p53 signals (blue arrows) in UV-irradiated, hyperproliferative
epidermis in a MnPV+ animal. C) Altered squamous cells migrating out of the epidermis
(black arrow) show strong p53 staining (blue arrow) (D) in an nKSCC (Scale bars: 100 μm).
(TIF)
S1 Table. Quantification of viral loads related to Fig 4A.
(PDF)
S2 Table. Viral loads corresponding to viral transcripts in Fig 4C.
(PDF)
S3 Table. Summarized sequencing results of Hras, Kras and Nras cDNAs of SCCs.
(PDF)
S4 Table. Overview and summary of primers used in this study.
(PDF)
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